Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines
Tài liệu tham khảo
Hauser, 1993, Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984, Epilepsia, 34, 453, 10.1111/j.1528-1157.1993.tb02586.x
Hauser, 1991, Prevalence of epilepsy in Rochester, Minnesota: 1940–1980, Epilepsia, 32, 429, 10.1111/j.1528-1157.1991.tb04675.x
French, 2004, Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy, Neurology, 62, 1252, 10.1212/01.WNL.0000123693.82339.FC
French, 2004, Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy, Neurology, 62, 1261, 10.1212/01.WNL.0000123695.22623.32
French, 1999, Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy, Neurology, 52, 1540, 10.1212/WNL.52.8.1540
Wong, 2000, Adverse reactions to new anticonvulsant drugs, Drug Saf, 23, 35, 10.2165/00002018-200023010-00003
Sheridan, 1996, The development of antiepileptic drugs for children: report from the NIH workshop, Bethesda, MD, Feb 17–18, 1994, Epilepsy Res, 23, 87, 10.1016/0920-1211(95)00043-7
Beghi, 2001, Epilepsia, 42, 1422, 10.1046/j.1528-1157.2001.11201.x
Karceski, 2001, The expert consensus guideline series: treatment of epilepsy, Epilepsy Behav, 2, A1, 10.1006/ebeh.2001.0283